NEO1 and central nervous system cancer: Cells with enhanced NEO1 expression exhibited an impaired ability of migration and invasion in two CRC cell lines (HCT 116, RKO) (Fig. 3A–D) and two Glioma cell lines (U87MG, U251) (Supplementary Fig. S4A–D).